E-mail lunthesis@163.com Phone 0551-65179860-203

GLOBALink | China speeds up anti-epidemic medicine production

Pub Date:2023-01-03 09:22 Source:Xinhua

Beijing, Jan. 1 (Xinhua) -- Pharmaceutical enterprises across China are working at full capacity to ensure the supply of key medicines for COVID-19 control, as the country optimizes its COVID-19 response.

Lanzhou Foci Pharmaceutical Co. in northwest China's Gansu Province has been working around the clock to produce medications for colds and respiratory infections.

Shandong Xinhua Pharmaceutical Co., Ltd. in east China's Shandong Province is specialized in producing fever reducers and pain relievers.

To meet the market demand, it has ramped up the production of ibuprofen 24 hours a day.

Its capacity has reached 10,000 tablets of ibuprofen per minute.

Meanwhile, efforts have also been made to ensure more targeted and reasonable medicine dispatching.

Priority will be given to the distribution of medical supplies to key places, such as medical institutions and nursing homes for the elderly.

Produced by Xinhua Global Service

Editor:Li Ruichuan

Related News
- GLOBALink | Vlog: How's life in Beijing amid refining of ...    2023-01-03 08:58
- 17 Hefei companies entered the unicorn club    2022-12-29 16:15
- Nation to downgrade COVID management    2022-12-28 10:02
- SOEs ramp up inland infrastructure projects    2022-12-28 09:00
photo  >>
Fill your spring scenery collection in Anhui
People enjoy themselves at eco-tourism scenic spot in Balidian, E China's Zhejiang
Video  >>
Volkswagen manager: I believe Chinese modernization is the right way
Let's meet inheritors: Luzhou dough modeling
People  >>
Sixty years on, hero soldier remains a role model in China
50 Years Friendship between China and Australia: Australian economist Tim Harcourt
Travel  >>
Iconic pine on China's Huangshan Mountain undergoes comprehensive examination
China sees over 73 mln domestic tourist visits during Mid-Autumn Festival holiday
Contact Us
Copyright ©2000-2021 anhuinews.com All rights reserved. Reproduction in whole or in part without permission is prohibited. 皖B2-20080023-7